Whats new
Whats new.
Maxim Group - New P2/3 AIPAC-003 Study Initiated with More Aggressive Dosing & OS Primary in Breast Cancer; Buy, $8 tgt (Jason McCarthy, PhD)
March 14th 2023
For a copy of this analyst report please contact your Maxim advisor
Whats new
March 14th 2023
For a copy of this analyst report please contact your Maxim advisor